PRODUCTS

ANDRAXAN 250 mg


Active Ingredient: Flutamid
Indication: Malignant diseases
Pharmaceutical Form: Tablet

ALOXI 250 μg/5ml


Active Ingredient: Palonosetron
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

ARİSTU 1 mg


Active Ingredient: Anastrozol
Indication: Malignant diseases
Pharmaceutical Form: Tablet

BLEOCIN-S 15 mg


Active Ingredient: Bleomycin
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IM, IV, IA

BOREA 160 mg


Active Ingredient: Megestrol acetate
Indication: Malignant diseases
Pharmaceutical Form: Tablet

EXETU 25 mg


Active Ingredient: Exemestane
Indication: Malignant diseases
Pharmaceutical Form: Tablet

İRONTU 100 mg/5 ml


Active Ingredient: Irinotecan
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

İRONTU 40 mg/2 ml


Active Ingredient: Irinotecan
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

LASTET 100mg amp


Active Ingredient: Etoposide
Indication: Malignant diseases
Pharmaceutical Form: Capsule, and Solution for IV

LASTET 100mg 10 caps


Active Ingredient: Etoposide
Indication: Malignant diseases
Pharmaceutical Form: Capsule, and Solution for IV

LASTET 50mg 20 caps


Active Ingredient: Etoposide
Indication: Malignant diseases
Pharmaceutical Form: Capsule, and Solution for IV

LASTET 25mg 40 caps


Active Ingredient: Etoposide
Indication: Malignant diseases
Pharmaceutical Form: Capsule, and Solution for IV

LETU 2,5 mg


Active Ingredient: Letrozole
Indication: Malignant diseases
Pharmaceutical Form: Tablet

MITOMYCIN-C 2 mg inj.


Active Ingredient: Mitomycin-C
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

MITOMYCIN-C 10 mg inj.


Active Ingredient: Mitomycin-C
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

MITOMYCIN-C 20 mg inj.


Active Ingredient: Mitomycin-C
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Cisplatinum Onko İnjection 10 mg/20 ml


Active Ingredient: Cisplatinium
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IV infusion

Cisplatinum Onko İnjection 25 mg/50 ml


Active Ingredient: Cisplatinium
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IV infusion

Cisplatinum Onko İnjection 50 mg/100 ml


Active Ingredient: Cisplatinium
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IV infusion

GEMTU 1000 mg /10 ml


Active Ingredient: Gemcitabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion

CARPLATU 450 mg/45 ml


Active Ingredient: Carplatinium
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

OXATU 50 mg


Active Ingredient: Oxaliplatin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Oxatu-S 50 mg/10 ml


Active Ingredient: Oxaliplatin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Oxatu-S 100 mg/20 ml


Active Ingredient: Oxaliplatin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Casomid 50 mg


Active Ingredient: Bicalutamide
Indication: Malignant diseases
Pharmaceutical Form: Tablet

Epiritu 50 mg/25 ml


Active Ingredient: Epirubicin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Mextu 50 mg/2 ml


Active Ingredient: Methotrexate
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion (IM, IA, IV, IT)

Pramitu 0.25 mg


Active Ingredient: Pramipexole
Indication: Systema Nervosum
Pharmaceutical Form: Tablet

Pramitu 1 mg


Active Ingredient: Pramipexole
Indication: Systema Nervosum
Pharmaceutical Form: Tablet

Epiritu 200 mg/100 ml


Active Ingredient: Epirubicin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Tacrotu 0.5 mg


Active Ingredient: Tacrolimus
Indication: Malignant diseases
Pharmaceutical Form: Capsule

Tacrotu 1 mg


Active Ingredient: Tacrolimus
Indication: Malignant diseases
Pharmaceutical Form: Capsule

Tacrotu 5 mg


Active Ingredient: Tacrolimus
Indication: Malignant diseases
Pharmaceutical Form: Capsule

Gemtu 2000 mg/20 ml


Active Ingredient: Gemcitabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion

Epiritu 10 mg/5 ml


Active Ingredient: Epirubicin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Topotu 4 mg/4 ml


Active Ingredient: Topotecan
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Gemtu 200 mg/2 ml


Active Ingredient: Gemcitabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion

5-Frotu 1000 mg/20 ml


Active Ingredient: 5-Fluoracil
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

5-Frotu 5000 mg/100 ml


Active Ingredient: 5-Fluoracil
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Doxtu 10 mg/5 ml


Active Ingredient: Doxorubicin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Doxtu 50 mg/25 ml


Active Ingredient: Doxorubicin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Carplatu 50 mg/5 ml


Active Ingredient: Carplatinium
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Carplatu 150 mg/15 ml


Active Ingredient: Carplatinium
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Zomtu 4 mg/5 ml


Active Ingredient: Zoledronic acid
Indication: Malignant diseases, Hypercalcemia
Pharmaceutical Form: Solution for injection

Zomtu 4 mg/100 ml


Active Ingredient: Zoledronic acid
Indication: Malignant diseases, Hypercalcemia
Pharmaceutical Form: Solution for injection

İRONTU 500mg/25 ml


Active Ingredient: Irinotecan
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Cytu 100 mg/ml


Active Ingredient: Cytarabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Cytu 500 mg/5ml


Active Ingredient: Cytarabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Cytu 1000 mg/10ml


Active Ingredient: Cytarabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Docetu 20 mg/ml


Active Ingredient: Docetaxel
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Docetu 80 mg/4 ml


Active Ingredient: Docetaxel
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Mextu 5000 mg /50 ml


Active Ingredient: Methotrexate
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion (IM, IA, IV, IT)

Mextu 500 mg /20 ml


Active Ingredient: Methotrexate
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion (IM, IA, IV, IT)

Mextu 1000 mg/40 ml


Active Ingredient: Methotrexate
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion (IM, IA, IV, IT)

Alkyloaxan Inj. 200 mg


Active Ingredient: Cyclophosphamide
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Alkyloaxan Inj. 500 mg


Active Ingredient: Cyclophosphamide
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

CYTARABINE Injection 100 mg


Active Ingredient: Cytarabine
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IV infusion

CYTARABINE Inj. 40 mg


Active Ingredient: Cytarabine
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IV infusion

UROKINASE-KGCC Inj. 500.000 IU Flakon


Active Ingredient: Urokinase
Indication: Malignant diseases
Pharmaceutical Form: Solution for injection

UROKINASE-KGCC Inj. 250.000 IU Flakon


Active Ingredient: Urokinase
Indication: Malignant diseases
Pharmaceutical Form: Solution for injection

5-FU Injection 250mg/5ml


Active Ingredient: 5-Fluoracil
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

KOPAQ 300 mgI/ML – 100 ml ve 50 ML


Active Ingredient: Iohexol
Indication: Contrast material for CT imaging
Pharmaceutical Form: Solution for infusion (IA, IV, intrathecal)

MESULID 100 mg tablet


Active Ingredient: Nimesulid
Indication: Antiinflammatory
Pharmaceutical Form: Oral suspension, and Tablet

Gadotu 287 mg/mL


Active Ingredient: Gadodiamid
Indication: Contrast material for MR imaging
Pharmaceutical Form: Solution for infusion

Kopaq 350 mg/ml


Active Ingredient: Iohexol
Indication: Contrast material for CT imaging
Pharmaceutical Form: Solution for infusion (IA, IV, intrathecal)

Pamintu 10 mg/ml


Active Ingredient: Protamine Sulphate
Indication: Heparin antagonist
Pharmaceutical Form: Solution for IV

Ravistu 300 mg


Active Ingredient: Iopromide
Indication: Contrast material for CT imaging
Pharmaceutical Form: Solution for infusion (IA, IV, intrathecal)

Ravistu 370 mg


Active Ingredient: Iopromide
Indication: Contrast material for CT imaging
Pharmaceutical Form: Solution for infusion (IA, IV, intrathecal)

Erastat 12.5 mg/ 50 mL


Active Ingredient: Tirofiban hydrochloride
Indication: Anticoagulant
Pharmaceutical Form: Solution for IV

Meksratu 25 mg/mL


Active Ingredient: Methotrexate
Indication: Antiinflammatory
Pharmaceutical Form: Prefilled syringe

Meksratu 20 mg/0,8mL


Active Ingredient: Methotrexate
Indication: Antiinflammatory
Pharmaceutical Form: Prefilled syringe

Meksratu 10 mg/0,4mL


Active Ingredient: Methotrexate
Indication: Antiinflammatory
Pharmaceutical Form: Prefilled syringe

Would you like to hear from us?

Subscribe to our e- bulletin to receive news regarding recent developments
about oncology and Onko.